Artigos de revistas sobre o tema "Myotonic Dystrophy type 1 (DM1)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Myotonic Dystrophy type 1 (DM1)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
García-Puga, Mikel, Ander Saenz-Antoñanzas, Ander Matheu e Adolfo López de Munain. "Targeting Myotonic Dystrophy Type 1 with Metformin". International Journal of Molecular Sciences 23, n.º 5 (7 de março de 2022): 2901. http://dx.doi.org/10.3390/ijms23052901.
Texto completo da fonteSoltanzadeh, Payam. "Myotonic Dystrophies: A Genetic Overview". Genes 13, n.º 2 (17 de fevereiro de 2022): 367. http://dx.doi.org/10.3390/genes13020367.
Texto completo da fonteRomigi, A., M. Albanese, C. Liguori, F. Placidi, M. G. Marciani e R. Massa. "Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies". Journal of Neurodegenerative Diseases 2013 (4 de novembro de 2013): 1–13. http://dx.doi.org/10.1155/2013/692026.
Texto completo da fonteKitsis, Elizabeth A., Fabreena Napier, Viral Juthani e Howard L. Geyer. "Association of Sjögren’s syndrome with myotonic dystrophy type 1". BMJ Case Reports 12, n.º 8 (agosto de 2019): e229611. http://dx.doi.org/10.1136/bcr-2019-229611.
Texto completo da fonteSouidi, Anissa, Monika Zmojdzian e Krzysztof Jagla. "Dissecting Pathogenetic Mechanisms and Therapeutic Strategies in Drosophila Models of Myotonic Dystrophy Type 1". International Journal of Molecular Sciences 19, n.º 12 (18 de dezembro de 2018): 4104. http://dx.doi.org/10.3390/ijms19124104.
Texto completo da fonteDay, J. W., K. Ricker, J. F. Jacobsen, L. J. Rasmussen, K. A. Dick, W. Kress, C. Schneider et al. "Myotonic dystrophy type 2". Neurology 60, n.º 4 (25 de fevereiro de 2003): 657–64. http://dx.doi.org/10.1212/01.wnl.0000054481.84978.f9.
Texto completo da fonteNeault, Nafisa, Aymeric Ravel-Chapuis, Stephen D. Baird, John A. Lunde, Mathieu Poirier, Emiliyan Staykov, Julio Plaza-Diaz et al. "Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model". International Journal of Molecular Sciences 24, n.º 4 (14 de fevereiro de 2023): 3794. http://dx.doi.org/10.3390/ijms24043794.
Texto completo da fonteMahadevan, Mani S., Ramesh S. Yadava e Mahua Mandal. "Cardiac Pathology in Myotonic Dystrophy Type 1". International Journal of Molecular Sciences 22, n.º 21 (2 de novembro de 2021): 11874. http://dx.doi.org/10.3390/ijms222111874.
Texto completo da fonteBallester-Lopez, Alfonsina, Judit Núñez-Manchón, Emma Koehorst, Ian Linares-Pardo, Miriam Almendrote, Giuseppe Lucente, Nicolau Guanyabens et al. "Three-dimensional imaging in myotonic dystrophy type 1". Neurology Genetics 6, n.º 4 (21 de julho de 2020): e484. http://dx.doi.org/10.1212/nxg.0000000000000484.
Texto completo da fonteBérenger-Currias, Noémie, Cécile Martinat e Sandrine Baghdoyan. "Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1". Cells 12, n.º 4 (10 de fevereiro de 2023): 571. http://dx.doi.org/10.3390/cells12040571.
Texto completo da fonteNieuwenhuis, Sylvia, Joanna Widomska, Paul Blom, Peter-Bram A. C. ‘t Hoen, Baziel G. M. van Engelen e Jeffrey C. Glennon. "Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1)". International Journal of Molecular Sciences 23, n.º 6 (12 de março de 2022): 3081. http://dx.doi.org/10.3390/ijms23063081.
Texto completo da fonteLee, Johanna E., e Thomas A. Cooper. "Pathogenic mechanisms of myotonic dystrophy". Biochemical Society Transactions 37, n.º 6 (19 de novembro de 2009): 1281–86. http://dx.doi.org/10.1042/bst0371281.
Texto completo da fonteAlegre-Cortés, Eva, Alberto Giménez-Bejarano, Elisabet Uribe-Carretero, Marta Paredes-Barquero, André R. A. Marques, Mafalda Lopes-da-Silva, Otília V. Vieira et al. "Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1)". Cells 11, n.º 19 (27 de setembro de 2022): 3018. http://dx.doi.org/10.3390/cells11193018.
Texto completo da fonteViegas, Diana, Cátia D. Pereira, Filipa Martins, Tiago Mateus, Odete A. B. da Cruz e Silva, Maria Teresa Herdeiro e Sandra Rebelo. "Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts". International Journal of Molecular Sciences 23, n.º 1 (4 de janeiro de 2022): 522. http://dx.doi.org/10.3390/ijms23010522.
Texto completo da fonteKoehorst, Emma, Alfonsina Ballester-Lopez, Virginia Arechavala-Gomeza, Alicia Martínez-Piñeiro e Gisela Nogales-Gadea. "The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I". Journal of Clinical Medicine 9, n.º 12 (4 de dezembro de 2020): 3939. http://dx.doi.org/10.3390/jcm9123939.
Texto completo da fonteMateus, Tiago, Filipa Martins, Alexandra Nunes, Maria Teresa Herdeiro e Sandra Rebelo. "Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin". International Journal of Environmental Research and Public Health 18, n.º 4 (12 de fevereiro de 2021): 1794. http://dx.doi.org/10.3390/ijerph18041794.
Texto completo da fonteOkkersen, Kees, Darren G. Monckton, Nhu Le, Anil M. Tuladhar, Joost Raaphorst e Baziel G. M. van Engelen. "Brain imaging in myotonic dystrophy type 1". Neurology 89, n.º 9 (2 de agosto de 2017): 960–69. http://dx.doi.org/10.1212/wnl.0000000000004300.
Texto completo da fonteCosta, Adriana, Ana C. Cruz, Filipa Martins e Sandra Rebelo. "Protein Phosphorylation Alterations in Myotonic Dystrophy Type 1: A Systematic Review". International Journal of Molecular Sciences 24, n.º 4 (4 de fevereiro de 2023): 3091. http://dx.doi.org/10.3390/ijms24043091.
Texto completo da fonteKetley, Ami, Marzena Wojciechowska, Sonja Ghidelli-Disse, Paul Bamborough, Tushar K. Ghosh, Marta Lopez Morato, Saam Sedehizadeh et al. "CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model". Science Translational Medicine 12, n.º 541 (29 de abril de 2020): eaaz2415. http://dx.doi.org/10.1126/scitranslmed.aaz2415.
Texto completo da fonteYadava, Ramesh S., Qing Yu, Mahua Mandal, Frank Rigo, C. Frank Bennett e Mani S. Mahadevan. "Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3′UTR RNA". Human Molecular Genetics 29, n.º 9 (2 de abril de 2020): 1440–53. http://dx.doi.org/10.1093/hmg/ddaa060.
Texto completo da fonteDhand, Upinder K., Faisal Raja e Kul Aggarwal. "Structural myocardial involvement in adult patients with type 1 myotonic dystrophy". Neurology International 5, n.º 1 (21 de março de 2013): 5. http://dx.doi.org/10.4081/ni.2013.e5.
Texto completo da fonteKaramlou, Milad, Iman Asaria, Jaime Barron, Petra Boutros, Vincent Fisher, Rachel Grandinetti, Julian Johnson et al. "Complications After Dental Sedation: A Myotonic Mystery Case Report". Anesthesia Progress 69, n.º 4 (1 de dezembro de 2022): 26–31. http://dx.doi.org/10.2344/anpr-69-02-09.
Texto completo da fonteVoellenkle, Perfetti, Carrara, Fuschi, Renna, Longo, Sain et al. "Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1". International Journal of Molecular Sciences 20, n.º 8 (19 de abril de 2019): 1938. http://dx.doi.org/10.3390/ijms20081938.
Texto completo da fonteScarano, Stefano, Antonio Caronni, Elena Carraro, Carola Rita Ferrari Aggradi, Viviana Rota, Chiara Malloggi, Luigi Tesio e Valeria Ada Sansone. "In Myotonic Dystrophy Type 1 Head Repositioning Errors Suggest Impaired Cervical Proprioception". Journal of Clinical Medicine 13, n.º 16 (9 de agosto de 2024): 4685. http://dx.doi.org/10.3390/jcm13164685.
Texto completo da fonteParent, Audrey, Laurent Ballaz, Bahare Samadi, Maria Vocos, Alain Steve Comtois e Annie Pouliot-Laforte. "Static Postural Control Deficits in Adults with Myotonic Dystrophy Type 1, Steinert Disease". Journal of Neuromuscular Diseases 9, n.º 2 (1 de março de 2022): 311–20. http://dx.doi.org/10.3233/jnd-210639.
Texto completo da fonteÁlvarez-Abril, Mari Carmen, Irma García-Alcover, Jordi Colonques-Bellmunt, Raquel Garijo, Manuel Pérez-Alonso, Rubén Artero e Arturo López-Castel. "Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSALR Mice". International Journal of Molecular Sciences 24, n.º 12 (6 de junho de 2023): 9820. http://dx.doi.org/10.3390/ijms24129820.
Texto completo da fonteSavić Pavićević, Dušanka, Jelena Miladinović, Miloš Brkušanin, Saša Šviković, Svetlana Djurica, Goran Brajušković e Stanka Romac. "Molecular Genetics and Genetic Testing in Myotonic Dystrophy Type 1". BioMed Research International 2013 (2013): 1–13. http://dx.doi.org/10.1155/2013/391821.
Texto completo da fonteThornton, C. "Strategies for treating myotonic dystrophy type 1 (DM1)". Neuromuscular Disorders 28 (abril de 2018): S1. http://dx.doi.org/10.1016/s0960-8966(18)30291-8.
Texto completo da fonteModoni, A., G. Silvestri, M. Gabriella Vita, D. Quaranta, P. A. Tonali e C. Marra. "Cognitive impairment in myotonic dystrophy type 1 (DM1)". Journal of Neurology 255, n.º 11 (24 de setembro de 2008): 1737–42. http://dx.doi.org/10.1007/s00415-008-0017-5.
Texto completo da fonteAntonini, Giovanni, Alessandro Clemenzi, Elisabetta Bucci, Stefania Morino, Matteo Garibaldi, Micaela Sepe-Monti, Franco Giubilei e Giuseppe Novelli. "Erectile dysfunction in myotonic dystrophy type 1 (DM1)". Journal of Neurology 256, n.º 4 (abril de 2009): 657–59. http://dx.doi.org/10.1007/s00415-009-0912-4.
Texto completo da fonteHo, Genevieve, Kate A. Carey, Michael Cardamone e Michelle A. Farrar. "Myotonic dystrophy type 1: clinical manifestations in children and adolescents". Archives of Disease in Childhood 104, n.º 1 (5 de junho de 2018): 48–52. http://dx.doi.org/10.1136/archdischild-2018-314837.
Texto completo da fonteXing, Xiaomeng, Anjani Kumari, Jake Brown e John David Brook. "Disrupting the Molecular Pathway in Myotonic Dystrophy". International Journal of Molecular Sciences 22, n.º 24 (8 de dezembro de 2021): 13225. http://dx.doi.org/10.3390/ijms222413225.
Texto completo da fonteLueck, John D., Ami Mankodi, Maurice S. Swanson, Charles A. Thornton e Robert T. Dirksen. "Muscle Chloride Channel Dysfunction in Two Mouse Models of Myotonic Dystrophy". Journal of General Physiology 129, n.º 1 (11 de dezembro de 2006): 79–94. http://dx.doi.org/10.1085/jgp.200609635.
Texto completo da fonteHilbert, James E., Richard J. Barohn, Paula R. Clemens, Elizabeth A. Luebbe, William B. Martens, Michael P. McDermott, Amy L. Parkhill, Rabi Tawil, Charles A. Thornton e Richard T. Moxley. "High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2". Neurology 89, n.º 13 (30 de agosto de 2017): 1348–54. http://dx.doi.org/10.1212/wnl.0000000000004420.
Texto completo da fonteVihola, A., G. Bassez, G. Meola, S. Zhang, H. Haapasalo, A. Paetau, E. Mancinelli et al. "Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2". Neurology 60, n.º 11 (10 de junho de 2003): 1854–57. http://dx.doi.org/10.1212/01.wnl.0000065898.61358.09.
Texto completo da fonteLi, Mao, Zhanjun Wang, Fang Cui, Fei Yang, Zhaohui Chen, Li Ling, Chuanqiang Pu e Xusheng Huang. "Investigation of molecular diagnosis in Chinese patients with myotonic dystrophy type 1". Chinese Medical Journal 127, n.º 6 (20 de março de 2014): 1084–88. http://dx.doi.org/10.3760/cma.j.issn.0366-6999.20132731.
Texto completo da fonteBallester-Lopez, Alfonsina, Ian Linares-Pardo, Emma Koehorst, Judit Núñez-Manchón, Guillem Pintos-Morell, Jaume Coll-Cantí, Miriam Almendrote et al. "The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1". Genes 11, n.º 7 (7 de julho de 2020): 757. http://dx.doi.org/10.3390/genes11070757.
Texto completo da fonteTimchenko, Lubov. "Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics". International Journal of Molecular Sciences 23, n.º 19 (8 de outubro de 2022): 11954. http://dx.doi.org/10.3390/ijms231911954.
Texto completo da fonteIkeda, Karin Suzete, Cristina Iwabe-Marchese, Marcondes Cavalcante França Jr, Anamarli Nucci e Keila Monteiro de Carvalho. "Myotonic dystrophy type 1: frequency of ophthalmologic findings". Arquivos de Neuro-Psiquiatria 74, n.º 3 (março de 2016): 183–88. http://dx.doi.org/10.1590/0004-282x20150218.
Texto completo da fonteLutz, Maggie, Miranda Levanti, Rebekah Karns, Genevieve Gourdon, Diana Lindquist, Nikolai A. Timchenko e Lubov Timchenko. "Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy". International Journal of Molecular Sciences 24, n.º 13 (26 de junho de 2023): 10650. http://dx.doi.org/10.3390/ijms241310650.
Texto completo da fonteRusso, Vincenzo, Antonio Capolongo, Roberta Bottino, Andreina Carbone, Alberto Palladino, Biagio Liccardo, Gerardo Nigro, Michał Marchel, Paolo Golino e Antonello D’Andrea. "Echocardiographic Features of Cardiac Involvement in Myotonic Dystrophy 1: Prevalence and Prognostic Value". Journal of Clinical Medicine 12, n.º 5 (1 de março de 2023): 1947. http://dx.doi.org/10.3390/jcm12051947.
Texto completo da fonteGagnon, Cynthia, Maud-Christine Chouinard, Luc Laberge, Diane Brisson, Daniel Gaudet, Mélissa Lavoie, Nadine Leclerc e Jean Mathieu. "Prevalence of Lifestyle Risk Factors in Myotonic Dystrophy Type 1". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 40, n.º 1 (janeiro de 2013): 42–47. http://dx.doi.org/10.1017/s0317167100012932.
Texto completo da fonteKuntawala, Dhvani H., Filipa Martins, Rui Vitorino e Sandra Rebelo. "Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1". International Journal of Environmental Research and Public Health 20, n.º 3 (27 de janeiro de 2023): 2283. http://dx.doi.org/10.3390/ijerph20032283.
Texto completo da fonteMateus, Tiago, Idália Almeida, Adriana Costa, Diana Viegas, Sandra Magalhães, Filipa Martins, Maria Teresa Herdeiro et al. "Fourier-Transform Infrared Spectroscopy as a Discriminatory Tool for Myotonic Dystrophy Type 1 Metabolism: A Pilot Study". International Journal of Environmental Research and Public Health 18, n.º 7 (6 de abril de 2021): 3800. http://dx.doi.org/10.3390/ijerph18073800.
Texto completo da fonteGrande, Valentina, Denisa Hathazi, Emily O’Connor, Theo Marteau, Ulrike Schara-Schmidt, Andreas Hentschel, Genevieve Gourdon, Nikoletta Nikolenko, Hanns Lochmüller e Andreas Roos. "Dysregulation of GSK3β-Target Proteins in Skin Fibroblasts of Myotonic Dystrophy Type 1 (DM1) Patients". Journal of Neuromuscular Diseases 8, n.º 4 (30 de julho de 2021): 603–19. http://dx.doi.org/10.3233/jnd-200558.
Texto completo da fonteWansink, D. G., e B. Wieringa. "Transgenic mouse models for myotonic dystrophy type 1 (DM1)". Cytogenetic and Genome Research 100, n.º 1-4 (2003): 230–42. http://dx.doi.org/10.1159/000072859.
Texto completo da fonteIzzo, Mariapaola, Jonathan Battistini, Claudia Provenzano, Fabio Martelli, Beatrice Cardinali e Germana Falcone. "Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing". International Journal of Molecular Sciences 23, n.º 9 (21 de abril de 2022): 4622. http://dx.doi.org/10.3390/ijms23094622.
Texto completo da fonteIonova, Sofya A., Aysylu F. Murtazina, Andrey A. Marakhonov, Olga A. Shchagina, Nina V. Ryadninskaya, Inna S. Tebieva, Vitaly V. Kadyshev et al. "The Study of the Inheritance Mechanisms of Myotonic Dystrophy Type 1 (DM1) in Families from the Republic of North Ossetia-Alania". International Journal of Molecular Sciences 25, n.º 17 (9 de setembro de 2024): 9734. http://dx.doi.org/10.3390/ijms25179734.
Texto completo da fonteHerrendorff, Ruben, Maria Teresa Faleschini, Adeline Stiefvater, Beat Erne, Tatiana Wiktorowicz, Frances Kern, Matthias Hamburger, Olivier Potterat, Jochen Kinter e Michael Sinnreich. "Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I". Journal of Biological Chemistry 291, n.º 33 (13 de junho de 2016): 17165–77. http://dx.doi.org/10.1074/jbc.m115.710616.
Texto completo da fonteEspinosa-Espinosa, Jorge, Anchel González-Barriga, Arturo López-Castel e Rubén Artero. "Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies". International Journal of Molecular Sciences 23, n.º 3 (27 de janeiro de 2022): 1441. http://dx.doi.org/10.3390/ijms23031441.
Texto completo da fonte